The arrival of Retatrutide ZPHC, at a dosage of 120mg, is generating considerable excitement within the medical community. This groundbreaking dual GIP and GLP-1 receptor medication appears to provide notable improvements in weight shedding compared to previous therapies. Early patient trials have demonstrated significant reductions in body fat per